Motus GI Holdings (MOTS) Reports In-Line Q4 EPS

Go back to Motus GI Holdings (MOTS) Reports In-Line Q4 EPS

Motus GI Holdings (MOTS) Receives CE Mark Approval for GEN2 Pure-Vu System

March 27, 2020 9:13 AM EDT

Motus GI Holdings, Inc., (NASDAQ: MOTS), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today announced receiving CE (Conformité Européene) Mark approval for the GEN2 Pure-Vu System. The Company is assessing potential strategic partnership opportunities for... More